Luca Micci

机构：Merck & Co., Inc., Rahway, NJ, USA (United States), Walter Reed National Military Medical Center, Neurology, Inc · ORCID：0000-0003-1980-4271

发表论文 47 篇 · 总被引 1592 次 · h-index 20

代表论文

• CTLA-4+PD-1− Memory CD4+ T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques (2017 · Immunity · 被引 163)
• CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption (2020 · Nature Medicine · 被引 109)
• IL-21 and IFNα therapy rescues terminally differentiated NK cells and limits SIV reservoir in ART-treated macaques (2021 · Nature Communications · 被引 43)
• Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy (2022 · DOAJ (DOAJ: Directory of Open Access Journals) · 被引 41)
• Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART (2021 · PLoS Pathogens · 被引 30)
• Fingolimod retains cytolytic T cells and limits T follicular helper cell infection in lymphoid sites of SIV persistence (2019 · PLoS Pathogens · 被引 30)